Biogen reports positive results with Alzheimer’s drug, reviving hopes for once-failed treatment

Biogen is declaring success with a once-failed treatment for Alzheimer’s disease, pointing to positive secondary results from a mid-stage study in hopes of saving a drug many in the field had written off entirely.